NCT07348289 PIVO Use for Blood Cultures in the Emergency Department
| NCT ID | NCT07348289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Intermountain Health Care, Inc. |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2025-10-01 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will implement a protocol for use of the PIVO device for blood culture collection in the emergency department. This protocol utilizes the device in various scenarios to reduce needlesticks while allowing for accurate and appropriate assessment of potential pathogens in the bloodstream. The study team will train staff on use of the device then monitor utilization and contamination rates among emergency department patients.
Eligibility Criteria
Inclusion Criteria: Patients in whom blood cultures are obtained in the emergency department. \- Exclusion Criteria: none \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07348289 clinical trial?
This trial is open to participants of all sexes, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07348289 currently recruiting?
Yes, NCT07348289 is actively recruiting participants. Contact the research team at troy.madsen@imail.org for enrollment information.
Where is the NCT07348289 trial being conducted?
This trial is being conducted at Park City, United States.
Who is sponsoring the NCT07348289 clinical trial?
NCT07348289 is sponsored by Intermountain Health Care, Inc.. The trial plans to enroll 10,000 participants.